Aditya Birla Sun Life Pharma and Healthcare Fund
Direct · Growth ₹34.32
21 Apr 2026
NAV
19.1%
3Y CAGR
21.1%
5Y CAGR
20.8%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
3.21
Sharpe
-20.5%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹13.16 L | 24.0% | -27.8% | 86.2% |
| 3 Years | ₹36.00 L | ₹46.79 L | 18.6% | -0.2% | 38.4% |
| 5 Years | ₹60.00 L | ₹95.77 L | 20.7% | 13.8% | 28.9% |
Fund SIP vs NIFTY 50
| Duration | Fund XIRR | Benchmark CAGR | Difference |
|---|---|---|---|
| 1 Year | 24.0% | 1.0% | +23.0% |
| 3 Years | 18.6% | 11.4% | +7.2% |
| 5 Years | 20.7% | 11.3% | +9.4% |